Commentary

Page 5

Posts about this type

PCC
Commentary

May 28, 2020

Here, read about the challenges faced by consultation-liaison psychiatrists during the COVID-19 outbreak and the pros and cons of telepsychiatry.
Miguel Ángel Sánchez-González
PCC
Commentary

May 28, 2020

During the COVID-19 pandemic, there may be less monitoring and identification of bullying behaviors and reduced opportunity for victims to access necessary support. Read this commentary to find out...
Ahmed Saeed Yahya, Shakil Khawaja, Jude Chukwuma
PCC
Commentary

May 28, 2020

The FDA has approved remdesivir for severe COVID-19 in children and adults. This commentary reviews potential interactions of remdesivir with psychotropic medications.
Zeeshan Mansuri, Bhumika Shah, Muhammad Khalid Zafar, et al
PCC
Commentary

May 21, 2020

This commentary discusses the challenges faced by health care providers in psychiatric wards during the COVID-19 pandemic.
Shivali Patel, Mohan Gautam, Gregory Mahr
PCC
Commentary

May 21, 2020

Various novel pharmacologic treatments are being considered for COVID-19. The authors of this commentary briefly discuss some of these proposed treatments and their possible psychiatric adverse effects.
Ahmed Saeed Yahya, Shakil Khawaja, Jude Chukwuma
JCP
Commentary

May 19, 2020

Read commentary on inadequate antidepressant response for MDD. Determining where patients are on the response continuum and managing inadequate response.
George I. Papakostas, W. Clay Jackson, Roueen Rafeyan, et al
PCC
Commentary

May 14, 2020

This commentary explores the association between past viral outbreaks and suicide to highlight current and future challenges patients may face in response to the COVID-19 pandemic.
Aminah Khan, Mohan Gautam, Mansi Chawa, et al
JCP
Commentary

May 12, 2020

This commentary notes the findings and implications of a recent study by Rommel et al and discusses possible risks of perinatal antidepressant treatment in light of the need to...
Ruta M. Nonacs, Lee S. Cohen
JCP
Commentary

May 12, 2020

This commentary discusses a recent report by Iltis and colleagues.
Philippe Courtet, Bénédicte Nobile
PCC
Commentary

May 7, 2020

In this commentary, Dr Pinkhasov discusses the challenges faced by health care providers and the Department of Behavioral Health at NYU Winthrop Hospital during the COVID-19 pandemic.
Aaron Pinkhasov
PCC
Commentary

May 7, 2020

Could social isolation and fear generated by COVID-19 increase intimate partner violence? This commentary looks at the associations between the COVID-19 crisis and domestic violence and stresses the importance...
Ahmed Saeed Yahya, Shakil Khawaja, Jude Chukwuma
PCC
Commentary

April 30, 2020

In this commentary, the authors discuss the risks associated with use of hydroxychloroquine in COVID-19-infected patients with schizophrenia.
N. A. Uvais
JCP
Commentary

April 28, 2020

Although the COVID-19 pandemic has impacted everyone in some way, those with serious mental illness (SMI) may face unique challenges. This commentary looks at the consequences of both the...
Ann K. Shinn, Mark Viron
PCC
Commentary

April 16, 2020

In this commentary, the authors discuss the impact of COVID-19 on those with mental illness and in the field of psychiatry.
Ahmed Saeed Yahya, Shakil Khawaja, Jude Chukwuma
JCP
Commentary

April 14, 2020

Read commentary on the crisis in India due to the COVID-19 lockdown, including the ramifications for health care, food supply, economy, and daily life.
Chittaranjan Andrade
JCP
Commentary

April 14, 2020

Read commentary on the possibilities for treating patients who have suicidal thoughts and behaviors during the COVID-19 pandemic.
Philippe Courtet, Emilie Olié, Christophe Debien, et al
JCP
Commentary

April 7, 2020

During the COVID-19 pandemic, psychiatrists may respond to the "all hands on deck" call from health care institutions. This commentary looks at how expertise in distinguishing and managing normal...
Joseph F. Goldberg
JCP
Commentary

April 7, 2020

This commentary considers the ways in which resources related to psychiatry, including digital tools, clinical skills, and psychiatric medications, can be put to effective use in the context of...
Ginger E. Nicol, Jordan F. Karp, Angela M. Reiersen, et al
JCP
Commentary

March 31, 2020

In this commentary, Dr Corruble gives an account from the front lines of treating psychiatric patients during the COVID-19 outbreak in Paris, France.
Emmanuelle Corruble
JCP
Commentary

March 31, 2020

In this commentary, the authors describe the hospital environment and the protective measures being taken during the COVID-19 pandemic in a hospital in Tuscany, Italy.
Andrea Fagiolini, Alessandro Cuomo, Ellen Frank
JCP
Commentary

March 3, 2020

Read commentary on the possible reasons why placebo response rates in clinical trials for schizophrenia are increasing.
Thomas P. Laughren
JCP
Commentary

December 3, 2019

This commentary discusses the findings and implications of a recent post hoc study by Thase and colleagues on the utility of combinatorial pharmacogenomics in depression.
Joseph F. Goldberg
JCP
Commentary

November 26, 2019

This commentary discusses the findings and implications of a recent study by Gründer et al and also highlights the importance of following formulas to estimate creatinine clearance, reading package...
Sheldon H. Preskorn
JCP
Commentary

November 26, 2019

This commentary discusses common decisional uncertainties surrounding antidepressant discontinuation syndrome in the clinical setting and seeks to outline a roadmap for clinicians to drive research on this important topic.
Manish Kumar Jha

Celebrating
85 Years

Read the Journal of Clinical Psychiatry

Subscribe to read
more articles

Subscribe